Inventor · disambiguated record
Larry W. Tjoelker
Also filed as: TJOELKER LARRY · TJOELKER LARRY W
25 granted patents·12 pending applications·293 citations·filing 1994–2024
96Inventor score
Top patents by PatentIndex Score
37 records- 0192US10745274B1Nucleic acids encoding antibodies specifically binding to MASP-3OMEROS CORP·Filed 2020·Granted Aug 18, 2020·2 cites·13 claims
- 0291US6203790B1Platelet-activating factor acetylhydrolaseICOS CORP·Filed 2000·Granted Mar 20, 2001·21 cites·2 claims
- 0388US11883493B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2021·Granted Jan 30, 2024·1 cites·17 claims
- 0488US10870708B2Methods for inhibiting angiogenesis in a subject in need thereofOMEROS CORP·Filed 2017·Granted Dec 22, 2020·3 cites·3 claims
- 0587US11027015B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2020·Granted Jun 8, 2021·1 cites·19 claims
- 0687US2024342278A1Antibodies specifically binding to masp-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2023·Application pending·0 cites
- 0785US9677070B2Composition and method for diversification of target sequencesOMEROS CORP·Filed 2013·Granted Jun 13, 2017·6 cites·28 claims
- 0885US9102724B2Anti-FZD10 monoclonal antibodies and methods for their useCUMMINGS W JASON·Filed 2012·Granted Aug 11, 2015·15 cites·19 claims
- 0983US5532152APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1995·Granted Jul 2, 1996·39 cites·15 claims
- 1082US10639369B2Antibodies specifically binding to MASP-3 for the treatment of various diseases and disordersOMEROS CORP·Filed 2017·Granted May 5, 2020·2 cites·30 claims
- 1182US5641669APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1994·Granted Jun 24, 1997·29 cites·2 claims
- 1281US2024352152A1Methods for inhibiting angiogenesis in a subject in need thereofOMEROS CORP·Filed 2024·Application pending·0 cites
- 1381US2025122309A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2024·Application pending·0 cites
- 1477US11045544B2Methods of generating bioactive peptide-bearing antibodies and compositions comprising the sameOMEROS CORP·Filed 2017·Granted Jun 29, 2021·1 cites·2 claims
- 1573US5698403AMethods of detecting platelet-activating factor acetylhydrolase using antibodiesICOS CORP·Filed 1995·Granted Dec 16, 1997·22 cites·5 claims
- 1672US11981748B2Methods for inhibiting angiogenesis in a subject in need thereofOMEROS CORP·Filed 2020·Granted May 14, 2024·0 cites·2 claims
- 1772US6399571B1Chitinase chitin-binding fragmentsICOS CORP·Filed 1999·Granted Jun 4, 2002·27 cites·24 claims
- 1871US8609818B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionLEPPARD JOHN BENJAMIN·Filed 2012·Granted Dec 17, 2013·2 cites·38 claims
- 1971US6146625APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1998·Granted Nov 14, 2000·14 cites·12 claims
- 2071US6099836APlatelet-activating factor acetylhydrolase (PAF-AH) therapeutic usesICOS CORP·Filed 1998·Granted Aug 8, 2000·14 cites·2 claims
- 2169US9346888B2Generation of anti-FN14 monoclonal antibodies by ex-vivo accelerated antibody evolutionOMEROS CORP·Filed 2013·Granted May 24, 2016·1 cites·20 claims
- 2268US5977308APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1997·Granted Nov 2, 1999·18 cites·9 claims
- 2367US5605801AMethods of detecting lesions in the platelet-activating factor acetylhydrolase geneICOS CORP·Filed 1995·Granted Feb 25, 1997·16 cites·3 claims
- 2465US6045794APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1999·Granted Apr 4, 2000·16 cites·2 claims
- 2565US5656431APlatelet-activating factor acetylhydrolaseICOS CORP·Filed 1995·Granted Aug 12, 1997·15 cites·5 claims
- 2665US2021079117A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2020·Application pending·0 cites
- 2759US2003143216A1Chitinase chitin-binding fragmentsFiled 2002·Application pending·0 cites
- 2858US5847088AAntibodies specific for platelet-activating factor acetylhydrolaseICOS CORP·Filed 1995·Granted Dec 8, 1998·18 cites·15 claims
- 2958US2003072747A1Platelet-activating factor acetylhydrolaseICOS CORP·Filed 2001·Application pending·0 cites
- 3057US2001021379A1Platelet-activating factor acetylhydrolaseICOS CORP·Filed 2000·Application pending·0 cites
- 3157US2015017162A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2014·Application pending·0 cites
- 3256US2005100540A1Platelet-activating factor acetylhydrolaseFiled 2003·Application pending·0 cites
- 3355US2014363433A1Methods of Generating Bioactive Peptide-bearing Antibodies and Compositions Comprising the SameOMEROS CORP·Filed 2014·Application pending·0 cites
- 3452US2022265821A1Composition and methods of targeting the pre-b cell receptor for the treatment of leukemias and lymphomasPASCAL BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 3551US6200951B1Chitinase chitin-binding fragmentsICOS CORP·Filed 1998·Granted Mar 13, 2001·10 cites·10 claims
- 3642US9777065B2Anti-FZD10 monoclonal antibodies and methods for their useOMEROS CORP·Filed 2015·Granted Oct 3, 2017·0 cites·25 claims
- 3737US2011064743A1Human anti-cancer antibodiesHAMMOND PHILIP W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Larry W. Tjoelker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →